CN: 32-1845/R
ISSN: 2095-6975
WANG Chong-Zhi, Samantha ANDERSON, DU Wei, HE Tong-Chuan, YUAN Chun-Su. Red ginseng and cancer treatment[J]. 中国天然药物英文, 2016, 14(1): 7-16

Red ginseng and cancer treatment

WANG Chong-Zhi1, Samantha ANDERSON1, DU Wei2, HE Tong-Chuan3, YUAN Chun-Su1,4
1 Tang Center for Herbal Medicine Research, and Department of Anesthesia & Critical Care, The Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA;
2 Ben May Department for Cancer Research, The Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA;
3 Molecular Oncology Laboratory, Department of Orthopedic Surgery, The Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA;
4 Committee on Clinical Pharmacology and Pharmacogenomics, The Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA
The ginseng family, including Panax ginseng (Asian ginseng), Panax quinquefolius (American ginseng), and Panax notoginseng (notoginseng), is commonly used herbal medicine. White ginseng is prepared by air-drying after harvest, while red ginseng is prepared by a steaming or heating process. The anticancer activity of red ginseng is significantly increased, due to the production of active anticancer ginsenosides during the steaming treatment, compared with that of white ginseng. Thus far, anticancer studies have been mostly focused on Asian ginseng. In this article, we review the research progress made in the anticancer activities of red Asian ginseng, red American ginseng and red notoginseng. The major anticancer mechanisms of red ginseng compounds include cell cycle arrest, induction of apoptosis/paraptosis, and inhibition of angiogenesis. The structure-function relationship analysis has revealed that the protopanaxadiol group ginsenosides have more potent effects than the protopanaxatriol group. Sugar molecules in ginsenosides inversely impact the antiproliferative potential of these compounds. In addition, ginsenoside stereoselectivity and double bond position also influence the anticancer activity. Future studies should focus on characterizing active red ginseng derivatives as potential anticancer drugs.
关键词:    Red ginseng    Panax ginseng    Panax quinquefolius    Panax notoginseng    Cancer chemoprevention   
收稿日期: 2015-07-20
WANG Chong-Zhi,Tel:(+1)773-702-0166;
PDF(446 KB) Free
WANG Chong-Zhi 在本刊中的所有文章
Samantha ANDERSON 在本刊中的所有文章
DU Wei 在本刊中的所有文章
HE Tong-Chuan 在本刊中的所有文章
YUAN Chun-Su 在本刊中的所有文章
[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1):5-29.
[2] Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer[J]. N Engl J Med, 2006, 355(11):1114-1123.
[3] Puetz TW, Morley CA, Herring MP. Effects of creative arts therapies on psychological symptoms and quality of life in patients with cancer[J]. JAMA Intern Med, 2013, 173(11):960-969.
[4] Leggett S, Koczwara B, Miller M. The impact of complementary and alternative medicines on cancer symptoms, treatment side effects, quality of life, and survival in women with breast cancer-a systematic review[J]. Nutr Cancer, 2015, 67(3):373-391.
[5] Richardson MA, Straus SE. Complementary and alternative medicine:opportunities and challenges for cancer management and research[J]. Semin Oncol, 2002, 29(6):531-545.
[6] Barnes PM, Powell-Griner E, McFann K, et al. Complementary and alternative medicine use among adults:United States, 2002[J]. Adv Data, 2004, 343(343):1-19.
[7] Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children:United States, 2007[J]. Natl Health Stat Report, 2008, 12(12):1-23.
[8] Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care[J]. JAMA, 2001, 286(2):208-216.
[9] Yuan CS, Wei G, Dey L, et al. Brief communication:American ginseng reduces warfarin's effect in healthy patients:a randomized, controlled trial[J]. Ann Intern Med, 2004, 141(1):23-27.
[10] Qi LW, Wang CZ, Yuan CS. Isolation and analysis of ginseng:advances and challenges[J]. Nat Prod Rep, 2011, 28(3):467-495.
[11] Yang WZ, Hu Y, Wu WY, et al. Saponins in the genus Panax L. (Araliaceae):a systematic review of their chemical diversity[J]. Phytochemistry, 2014, 106:7-24.
[12] Baeg IH, So SH. The world ginseng market and the ginseng (Korea)[J]. J Ginseng Res, 2013, 37(1):1-7.
[13] Yun TK. Panax ginseng——a non-organ-specific cancer preventive?[J]. Lancet Oncol, 2001, 2(1):49-55.
[14] Yun TK. Experimental and epidemiological evidence on nonorgan specific cancer preventive effect of Korean ginseng and identification of active compounds[J]. Mutat Res, 2003, 523-524:63-74.
[15] Sun S, Qi LW, Du GJ, et al. Red notoginseng:higher ginsenoside content and stronger anticancer potential than Asian and American ginseng[J]. Food Chem, 2011, 125(4):1299-1305.
[16] Attele AS, Wu JA, Yuan CS. Ginseng pharmacology:multiple constituents and multiple actions[J]. Biochem Pharmacol, 1999, 58(11):1685-1693.
[17] Ouyang LF, Wang ZL, Dai JG, et al. Determination of total ginsenosides in ginseng extracts using charged aerosol detection with post-column compensation of the gradient[J]. Chin J Nat Med, 2014, 12(11):857-868.
[18] Shergis JL, Zhang AL, Zhou W, et al. Quality and risk of bias in Panax ginseng randomized controlled trials:a review[J]. Am J Chin Med, 2013, 41(2):231-252.
[19] Rhee MY, Cho B, Kim KI, et al. Blood pressure lowering effect of Korea ginseng derived ginseol K-g1[J]. Am J Chin Med, 2014, 42(3):605-618.
[20] Wang CZ, Mehendale SR, Yuan CS. Commonly used antioxidant botanicals:active constituents and their potential role in cardiovascular illness[J]. Am J Chin Med, 2007, 35(4):543-558.
[21] Lee TK, Johnke RM, Allison RR, et al. Radioprotective potential of ginseng[J]. Mutagenesis, 2005, 20(4):237-243.
[22] Chen YH, Lin YN, Chen WC, et al. Treatment of stress urinary incontinence by ginsenoside Rh2[J]. Am J Chin Med, 2014, 42(4):817-831.
[23] Lee YJ, Jin YR, Lim WC, et al. Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells[J]. Arch Pharm Res, 2003, 26(1):58-63.
[24] Mehendale SR, Aung HH, Yin JJ, et al. Effects of antioxidant herbs on chemotherapy-induced nausea and vomiting in a rat-pica model[J]. Am J Chin Med, 2004, 32(6):897-905.
[25] Mehendale S, Aung H, Wang A, et al. American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats[J]. Cancer Chemother Pharmacol, 2005, 56(1):63-69.
[26] Fishbein AB, Wang CZ, Li XL, et al. Asian ginseng enhances the anti-proliferative effect of 5-fluorouracil on human colorectal cancer:comparison between white and red ginseng[J]. Arch Pharm Res, 2009, 32(4):505-513.
[27] Gu C, Qiao J, Zhu M, et al. Preliminary evaluation of the interactions of Panax ginseng and Salvia miltiorrhiza Bunge with 5-fluorouracil on pharmacokinetics in rats and pharmacodynamics in human cells[J]. Am J Chin Med, 2013, 41(2):443-458.
[28] Yuan CS, Wang CZ, Wicks SM, et al. Chemical and pharmacological studies of saponins with a focus on American ginseng[J]. J Ginseng Res, 2010, 34(3):160-167.
[29] Qi LW, Wang CZ, Yuan CS. Ginsenosides from American ginseng:chemical and pharmacological diversity[J]. Phytochemistry, 2011, 72(8):689-699.
[30] Wang A, Wang CZ, Wu JA, et al. Determination of major ginsenosides in Panax quinquefolius (American ginseng) using high-performance liquid chromatography[J]. Phytochem Anal, 2005, 16(4):272-277.
[31] Wang CZ, Wu JA, McEntee E, et al. Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography[J]. J Agric Food Chem, 2006, 54(6):2261-2266.
[32] Park EY, Kim MH, Kim EH, et al. Efficacy comparison of Korean ginseng and American ginseng on body temperature and metabolic parameters[J]. Am J Chin Med, 2014, 42(1):173-187.
[33] Wu Y, Lu X, Xiang FL, et al. North American ginseng protects the heart from ischemia and reperfusion injury via upregulation of endothelial nitric oxide synthase[J]. Pharmacol Res, 2011, 64(3):195-202.
[34] Shao ZH, Xie JT, Vanden Hoek TL, et al. Antioxidant effects of American ginseng berry extract in cardiomyocytes exposed to acute oxidant stress[J]. Biochim Biophys Acta, 2004, 1670(3):165-171.
[35] Aung HH, Mehendale SR, Wang CZ, et al. Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng[J]. Cancer Chemother Pharmacol, 2007, 59(3):369-374.
[36] Liu J, Wang Y, Qiu L, et al. Saponins of Panax notoginseng:chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases[J]. Expert Opin Investig Drugs, 2014, 23(4):523-539.
[37] Wang CZ, McEntee E, Wicks S, et al. Phytochemical and analytical studies of Panax notoginseng (Burk.) F.H. Chen[J]. J Nat Med, 2006, 60(2):97-106.
[38] Wang JR, Yamasaki Y, Tanaka T, et al. Dammarane-type triterpene saponins from the flowers of Panax notoginseng[J]. Molecules, 2009, 14(6):2087-2094.
[39] Wang CZ, Ni M, Sun S, et al. Detection of adulteration of notoginseng root extract with other panax species by quantitative HPLC coupled with PCA[J]. J Agric Food Chem, 2009, 57(6):2363-2367.
[40] Huang LF, Shi HL, Gao B, et al. Decichine enhances hemostasis of activated platelets via AMPA receptors[J]. Thromb Res, 2014, 133(5):848-854.
[41] Xu Y, Lin L, Tang L, et al. Notoginsenoside R1 attenuates hypoxia and hypercapnia-induced vasoconstriction in isolated rat pulmonary arterial rings by reducing the expression of ERK[J]. Am J Chin Med, 2014, 42(4):799-816.
[42] Zhang HS, Wang SQ. Notoginsenoside R1 inhibits TNFalpha-induced fibronectin production in smooth muscle cells via the ROS/ERK pathway[J]. Free Radic Biol Med, 2006, 40(9):1664-1674.
[43] Huang SS, Deng JS, Lin JG, et al. Anti-inflammatory effects of trilinolein from Panax notoginseng through the suppression of NF-kappaB and MAPK expression and proinflammatory cytokine expression[J]. Am J Chin Med, 2014, 42(6):1485-1506.
[44] Yang CY, Wang J, Zhao Y, et al. Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components[J]. J Ethnopharmacol, 2010, 130(2):231-236.
[45] Konoshima T, Takasaki M, Tokuda H. Anti-carcinogenic activity of the roots of Panax notoginseng. II[J]. Biol Pharm Bull, 1999, 22(10):1150-1152.
[46] He NW, Zhao Y, Guo L, et al. Antioxidant, antiproliferative, and pro-apoptotic activities of a saponin extract derived from the roots of Panax notoginseng (Burk.) F.H. Chen[J]. J Med Food, 2012, 15(4):350-359.
[47] Qian M, Yi L, Song-Lin L, et al. Chemical profiles and anticancer effects of saponin fractions of different polarity from the leaves of Panax notoginseng[J]. Chin J Nat Med, 2014, 12(1):30-37.
[48] Wang CZ, Luo X, Zhang B, et al. Notoginseng enhances anticancer effect of 5-fluorouracil on human colorectal cancer cells[J]. Cancer Chemother Pharmacol, 2007, 60(1):69-79.
[49] Lee SA, Jo HK, Im BO, et al. Changes in the contents of prosapogenin in the red ginseng (Panax ginseng) depending on steaming batches[J]. J Ginseng Res, 2012, 36(1):102-106.
[50] Ren G, Zhang XW, Chen F. Predicting color kinetics during red Asian ginseng (Panax ginseng) preparation[J]. Pharmazie, 2000, 55(4):300-302.
[51] Wang CZ, Aung HH, Ni M, et al. Red American ginseng:ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots[J]. Planta Med, 2007, 73(7):669-674.
[52] Wang CZ, Zhang B, Song WX, et al. Steamed American ginseng berry:ginsenoside analyses and anticancer activities[J]. J Agric Food Chem, 2006, 54(26):9936-9942.
[53] Kang KS, Yamabe N, Kim HY, et al. Increase in the free radical scavenging activities of American ginseng by heat processing and its safety evaluation[J]. J Ethnopharmacol, 2007, 113(2):225-232.
[54] Kwon SW, Han SB, Park IH, et al. Liquid chromatographic determination of less polar ginsenosides in processed ginseng[J]. J Chromatogr A, 2001, 921(2):335-339.
[55] Quan K, Liu Q, Wan JY, et al. Rapid preparation of rare ginsenosides by acid transformation and their structure-activity relationships against cancer cells[J]. Sci Rep, 2015, 5:8598.
[56] Yun TK, Choi SY. Preventive effect of ginseng intake against various human cancers:a case-control study on 1987 pairs[J]. Cancer Epidemiol Biomarkers Prev, 1995, 4(4):401-408.
[57] Yun TK, Choi SY. A case-control study of ginseng intake and cancer[J]. Int J Epidemiol, 1990, 19(4):871-876.
[58] Yun TK, Lee YS, Lee YH, et al. Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds[J]. J Korean Med Sci, 2001, 16 Suppl:S6-18.
[59] Kim H, Hong MK, Choi H, et al. Chemopreventive effects of korean red ginseng extract on rat hepatocarcinogenesis[J]. J Cancer, 2015, 6(1):1-8.
[60] Wang CZ, Aung HH, Zhang B, et al. Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells[J]. Anticancer Res, 2008, 28(5A):2545-2551.
[61] Wang CZ, Zhang Z, Anderson S, et al. Natural products and chemotherapeutic agents on cancer:prevention vs. treatment[J]. Am J Chin Med, 2014, 42(6):1555-1558.
[62] Lin Y, Jiang D, Li Y, et al. Effect of sun ginseng potentiation on epirubicin and paclitaxel-induced apoptosis in human cervical cancer cells[J]. J Ginseng Res, 2015, 39(1):22-28.
[63] Kim SJ, Kwak HJ, Kim DS, et al. Protective mechanism of Korean Red Ginseng in cisplatin-induced ototoxicity through attenuation of nuclear factor-kappaB and caspase-1 activation[J]. Mol Med Rep, 2015, 12(1):315-322.
[64] Kim YJ, Chung JW, Lee SJ, et al. Progression from chronic atrophic gastritis to gastric cancer; tangle, toggle, tackle with Korea red ginseng[J]. J Clin Biochem Nutr, 2010, 46(3):195-204.
[65] Nabel EG. CDKs and CKIs:molecular targets for tissue remodelling[J]. Nat Rev Drug Discov, 2002, 1(8):587-598.
[66] Zhang YL, Zhang R, Xu HL, et al. 20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway[J]. Am J Chin Med, 2013, 41(5):1137-1152.
[67] Wang CZ, Zhang Z, Wan JY, et al. Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer[J]. Nutrients, 2015, 7(2):799-814.
[68] Choi S, Kim TW, Singh SV. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclindependent kinases[J]. Pharm Res, 2009, 26(10):2280-2288.
[69] Kim SE, Lee YH, Park JH, et al. Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells[J]. Eur J Cancer, 1999, 35(3):507-511.
[70] Gao JL, Lv GY, He BC, et al. Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways[J]. Oncol Rep, 2013, 30(1):292-298.
[71] Czabotar PE, Lessene G, Strasser A, et al. Control of apoptosis by the BCL-2 protein family:implications for physiology and therapy[J]. Nat Rev Mol Cell Biol, 2014, 15(1):49-63.
[72] Park HM, Kim SJ, Kim JS, et al. Reactive oxygen species mediated ginsenoside Rg3-and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways[J]. Food Chem Toxicol, 2012, 50(8):2736-2741.
[73] Cheong JH, Kim H, Hong MJ, et al. Stereoisomer-specific anticancer activities of ginsenoside Rg3 and Rh2 in HepG2 cells:disparity in cytotoxicity and autophagy-inducing effects due to 20(S)-epimers[J]. Biol Pharm Bull, 2015, 38(1):102-108.
[74] Jin YH, Yim H, Park JH, et al. Cdk2 activity is associated with depolarization of mitochondrial membrane potential during apoptosis[J]. Biochem Biophys Res Commun, 2003, 305(4):974-980.
[75] Zhang Z, Li Z, Wu X, et al. TRAIL pathway is associated with inhibition of colon cancer by protopanaxadiol[J]. J Pharmacol Sci, 2015, 127(1):83-91.
[76] Hoa N, Myers MP, Douglass TG, et al. Molecular mechanisms of paraptosis induction:implications for a non-genetically modified tumor vaccine[J]. PLoS One, 2009, 4(2):e4631.
[77] Li B, Zhao J, Wang CZ, et al. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53[J]. Cancer Lett, 2011, 301(2):185-192.
[78] Wang CZ, Li B, Wen XD, et al. Paraptosis and NF-kappaB activation are associated with protopanaxadiol-induced cancer chemoprevention[J]. BMC Complement Altern Med, 2013, 13:2.
[79] Folkman J. Angiogenesis:an organizing principle for drug discovery?[J]. Nat Rev Drug Discov, 2007, 6(4):273-286.
[80] Leung KW, Cheung LW, Pon YL, et al. Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor[J]. Br J Pharmacol, 2007, 152(2):207-215.
[81] Yue PY, Wong DY, Wu PK, et al. The angiosuppressive effects of 20(R)-ginsenoside Rg3[J]. Biochem Pharmacol, 2006,72(4):437-445.
[82] Zhou B, Wang J, Yan Z. Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model[J]. Onco Targets Ther, 2014, 7:1945-1954.
[83] Bae J, Koo J, Kim S, et al. Ginsenoside Rp1 exerts anti-inflammatory effects via activation of dendritic cells and regulatory T cells[J]. J Ginseng Res, 2012, 36(4):375-382.
[84] Mochizuki M, Yoo YC, Matsuzawa K, et al. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)-and 20(S)-ginsenoside-Rg3, of red ginseng[J]. Biol Pharm Bull, 1995, 18(9):1197-1202.
[85] Popovich DG, Kitts DD. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line[J]. Arch Biochem Biophys, 2002, 406(1):1-8.
[86] Li W, Liu Y, Zhang JW, et al. Anti-androgen-independent prostate cancer effects of ginsenoside metabolites in vitro:mechanism and possible structure-activity relationship investigation[J]. Arch Pharm Res, 2009, 32(1):49-57.
[87] Wang W, Zhao Y, Rayburn ER, et al. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng[J]. Cancer Chemother Pharmacol, 2007, 59(5):589-601.
[88] Lee SY, Kim GT, Roh SH, et al. Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines[J]. Biosci Biotechnol Biochem, 2009, 73(4):811-816.